Sotera Health Management
Management criteria checks 3/4
Sotera Health's CEO is Michael Petras, appointed in Jun 2016, has a tenure of 8.5 years. total yearly compensation is $9.70M, comprised of 10.8% salary and 89.2% bonuses, including company stock and options. directly owns 1.92% of the company’s shares, worth $72.10M. The average tenure of the management team and the board of directors is 4.2 years and 4.1 years respectively.
Key information
Michael Petras
Chief executive officer
US$9.7m
Total compensation
| CEO salary percentage | 10.8% |
| CEO tenure | 8.5yrs |
| CEO ownership | 1.9% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Here's Why Sotera Health (NASDAQ:SHC) Has A Meaningful Debt Burden
Dec 05
Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable
Sep 02Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt
Jun 25Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate
May 30The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%
Mar 21Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models
Mar 01McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount
Feb 08Is Sotera Health (NASDAQ:SHC) A Risky Investment?
Feb 06Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump
Dec 28Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price
Dec 11An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued
Sep 10Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jun 05Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?
Feb 13Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher
Nov 24Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit
Sep 19Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?
Sep 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$70m |
| Jun 30 2024 | n/a | n/a | US$40m |
| Mar 31 2024 | n/a | n/a | US$55m |
| Dec 31 2023 | US$10m | US$1m | US$51m |
| Sep 30 2023 | n/a | n/a | -US$306m |
| Jun 30 2023 | n/a | n/a | -US$268m |
| Mar 31 2023 | n/a | n/a | -US$261m |
| Dec 31 2022 | US$17m | US$1m | -US$234m |
| Sep 30 2022 | n/a | n/a | US$121m |
| Jun 30 2022 | n/a | n/a | US$123m |
| Mar 31 2022 | n/a | n/a | US$135m |
| Dec 31 2021 | US$2m | US$1m | US$115m |
| Sep 30 2021 | n/a | n/a | US$36m |
| Jun 30 2021 | n/a | n/a | US$9m |
| Mar 31 2021 | n/a | n/a | -US$26m |
| Dec 31 2020 | US$17m | US$728k | -US$39m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$28m |
| Mar 31 2020 | n/a | n/a | -US$29m |
| Dec 31 2019 | US$2m | US$700k | -US$21m |
Compensation vs Market: Michael's total compensation ($USD9.70M) is above average for companies of similar size in the US market ($USD6.67M).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Petras (55 yo)
8.5yrs
Tenure
US$9,701,005
Compensation
Mr. Michael B. Petras Jr., serves as Chief Executive Officer at Sotera Health Company since June 20, 2016. He has been Chairman of the Board at Sotera Health Company since October 2020. He also served as t...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$9.70m | 1.92% $ 72.1m | |
| Senior VP & CFO | 1.5yrs | US$2.18m | 0.039% $ 1.5m | |
| Senior VP | 2.1yrs | US$862.18k | 0.083% $ 3.1m | |
| President of Sterigenics | 4.2yrs | US$2.03m | 0.17% $ 6.4m | |
| Chief Information Officer | 5.9yrs | no data | no data | |
| Chief Marketing Officer | 8.1yrs | no data | no data | |
| Senior Vice President of Strategy & Corporate Development | 2.9yrs | no data | no data | |
| Chief Human Resources Officer | 5.9yrs | no data | no data | |
| Senior Vice President of Global Environmental | less than a year | no data | no data | |
| President of Nelson Labs | 4.2yrs | no data | no data | |
| President of Nordion | 2.8yrs | no data | no data | |
| VP & Treasurer | no data | no data | no data |
4.2yrs
Average Tenure
54.5yo
Average Age
Experienced Management: SHC's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$9.70m | 1.92% $ 72.1m | |
| Independent Director | 4.2yrs | US$320.00k | 0.015% $ 550.1k | |
| Independent Director | 4.2yrs | US$305.00k | 0.015% $ 550.1k | |
| Independent Director | 4.2yrs | US$302.50k | 0.015% $ 550.1k | |
| Independent Director | 4.1yrs | US$325.00k | 0.015% $ 550.1k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 4.2yrs | US$322.50k | 0.031% $ 1.1m | |
| Independent Director | 2.2yrs | US$300.00k | 0.0056% $ 208.1k | |
| Independent Director | 4.1yrs | US$302.50k | 0.015% $ 550.1k | |
| Independent Director | 3.6yrs | US$310.00k | 0.013% $ 472.5k | |
| Independent Director | 1.1yrs | US$9.99k | no data |
4.1yrs
Average Tenure
61yo
Average Age
Experienced Board: SHC's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 11:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sotera Health Company is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Luke Sergott | Barclays |
| Patrick Donnelly | Citigroup Inc |